Erkang Pharmaceuticals: Net profit in the first half of 2025 increased by 497.36% year-on-year.

Erkang Pharmaceutical announced that its operating income in the first half of 2025 was 682 million yuan, a year-on-year increase of 9.74%. Net profit was 37.6346 million yuan, a year-on-year increase of 497.36%.